Except for the work by Gerber and colleagues 25, most studies reported to date on the gene expression profiles of CML cells have used whole MNC or CD34+ cells as the target population. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.